JP2013524810A5 - - Google Patents

Download PDF

Info

Publication number
JP2013524810A5
JP2013524810A5 JP2013506194A JP2013506194A JP2013524810A5 JP 2013524810 A5 JP2013524810 A5 JP 2013524810A5 JP 2013506194 A JP2013506194 A JP 2013506194A JP 2013506194 A JP2013506194 A JP 2013506194A JP 2013524810 A5 JP2013524810 A5 JP 2013524810A5
Authority
JP
Japan
Prior art keywords
allele
human
cvd
hmg
coa reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013506194A
Other languages
English (en)
Japanese (ja)
Other versions
JP5918216B2 (ja
JP2013524810A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/032665 external-priority patent/WO2011133418A1/en
Publication of JP2013524810A publication Critical patent/JP2013524810A/ja
Publication of JP2013524810A5 publication Critical patent/JP2013524810A5/ja
Application granted granted Critical
Publication of JP5918216B2 publication Critical patent/JP5918216B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013506194A 2010-04-19 2011-04-15 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用 Active JP5918216B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US32568910P 2010-04-19 2010-04-19
US61/325,689 2010-04-19
US33250910P 2010-05-07 2010-05-07
US61/332,509 2010-05-07
US40597210P 2010-10-22 2010-10-22
US61/405,972 2010-10-22
PCT/US2011/032665 WO2011133418A1 (en) 2010-04-19 2011-04-15 Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015230300A Division JP6157571B2 (ja) 2010-04-19 2015-11-26 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用

Publications (3)

Publication Number Publication Date
JP2013524810A JP2013524810A (ja) 2013-06-20
JP2013524810A5 true JP2013524810A5 (https=) 2014-05-15
JP5918216B2 JP5918216B2 (ja) 2016-05-18

Family

ID=44834462

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2013506194A Active JP5918216B2 (ja) 2010-04-19 2011-04-15 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2015230300A Active JP6157571B2 (ja) 2010-04-19 2015-11-26 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2017000353A Withdrawn JP2017063795A (ja) 2010-04-19 2017-01-05 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2018141168A Withdrawn JP2018161156A (ja) 2010-04-19 2018-07-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2020031256A Withdrawn JP2020096638A (ja) 2010-04-19 2020-02-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2020031255A Active JP6839779B2 (ja) 2010-04-19 2020-02-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2021196089A Active JP7175371B2 (ja) 2010-04-19 2021-12-02 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2021196090A Pending JP2022033878A (ja) 2010-04-19 2021-12-02 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用

Family Applications After (7)

Application Number Title Priority Date Filing Date
JP2015230300A Active JP6157571B2 (ja) 2010-04-19 2015-11-26 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2017000353A Withdrawn JP2017063795A (ja) 2010-04-19 2017-01-05 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2018141168A Withdrawn JP2018161156A (ja) 2010-04-19 2018-07-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2020031256A Withdrawn JP2020096638A (ja) 2010-04-19 2020-02-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2020031255A Active JP6839779B2 (ja) 2010-04-19 2020-02-27 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2021196089A Active JP7175371B2 (ja) 2010-04-19 2021-12-02 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2021196090A Pending JP2022033878A (ja) 2010-04-19 2021-12-02 スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用

Country Status (5)

Country Link
US (5) US20110269735A1 (https=)
EP (4) EP2561352B1 (https=)
JP (8) JP5918216B2 (https=)
CA (2) CA3060628C (https=)
WO (1) WO2011133418A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2744797T3 (es) * 2008-02-29 2020-02-26 Univ Oxford Innovation Ltd Procedimiento de determinación de una dosis adecuada de estatina
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
EP2554679B1 (en) * 2011-08-05 2016-03-02 Gendiag.exe, S.L. Genetic markers for cardiovascular disease risk assessment
EP2766728B1 (en) * 2011-10-13 2017-09-06 Boston Heart Diagnostics Compositions and methods for treating and preventing coronary heart disease
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
AU2015327836B2 (en) 2014-10-03 2021-07-01 Cold Spring Harbor Laboratory Targeted augmentation of nuclear gene output
EP3220810A4 (en) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment
WO2017044507A2 (en) * 2015-09-08 2017-03-16 Sirnaomics, Inc. Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
CN108603230A (zh) 2015-10-09 2018-09-28 南安普敦大学 基因表达的调节与蛋白质表达失调的筛选
CA3001594A1 (en) * 2015-10-14 2017-04-20 Audentes Therapeutics, Inc. Nucleic acid molecules containing spacers and methods of use thereof
WO2017106377A1 (en) 2015-12-14 2017-06-22 Cold Spring Harbor Laboratory Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
EP3390666A4 (en) * 2015-12-14 2019-08-07 Cold Spring Harbor Laboratory COMPOSITIONS AND METHODS OF TREATING NURSE DISEASES
WO2018138709A1 (en) * 2017-01-30 2018-08-02 National Research Council Of Canada Blood-brain barrier transmigrating compounds and uses thereof
JP2019022483A (ja) * 2017-07-21 2019-02-14 ポーラ化成工業株式会社 肌トラブルリスクの検出方法、その方法に使用するための検出試薬、肌状態鑑別用試薬、及び化粧品又は医薬部外品の選択方法
KR102318434B1 (ko) 2017-08-25 2021-11-01 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
CA3099280A1 (en) 2018-05-04 2019-11-07 Stoke Therapeutics, Inc. Methods and compositions for treatment of cholesteryl ester storage disease
KR102205831B1 (ko) * 2018-09-21 2021-01-21 주식회사 녹십자지놈 혈중 스타틴 약물농도 예측을 위한 유전자 마커
AU2020227825B2 (en) 2019-02-27 2026-03-26 Stoke Therapeutics, Inc. Antisense oligomers for treatment of conditions and diseases
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CN115867657A (zh) 2020-05-11 2023-03-28 斯托克制药公司 用于治疗疾患和疾病的opa1反义寡聚物
JP2022029001A (ja) * 2020-07-31 2022-02-17 株式会社三洋物産 遊技機
CN114230626B (zh) * 2021-11-05 2024-09-17 康龙化成(宁波)科技发展有限公司 一种可在寡聚核酸上一锅法合成四元环内酰胺的方法
WO2024102688A1 (en) * 2022-11-07 2024-05-16 New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery Compositions for treating osteoclastogenesis disorders and/or rheumatoid arthritis

Family Cites Families (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US620332A (en) 1899-02-28 Reel mechanism
US117329A (en) 1871-07-25 Improvement in parlor-skates
US620333A (en) 1899-02-28 Benjamin g
US3320311A (en) 1963-07-17 1967-05-16 Union Oil Co N-cycloalkylidene-n'-cycloalkyl-1-enyl-thioureas and method of preparation
US3330311A (en) 1964-10-19 1967-07-11 Allen Electronics Inc Mechanism for filling receptacles or packets with dry powdered material
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
FR2540122B1 (fr) 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
NO870613L (no) 1986-03-05 1987-09-07 Molecular Diagnostics Inc Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
US5004565A (en) 1986-07-17 1991-04-02 The Board Of Governors Of Wayne State University Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5856522A (en) 1995-05-04 1999-01-05 Tropix, Inc. Method of using synthesis of 1,2-dioxetanes and kits therefore
US4988617A (en) 1988-03-25 1991-01-29 California Institute Of Technology Method of detecting a nucleotide change in nucleic acids
JP2897959B2 (ja) 1988-05-20 1999-05-31 エフ．ホフマン―ラ ロシュ アクチェンゲゼルシャフト 固定化された配列特異的プローブ
US4988167A (en) 1988-08-10 1991-01-29 Fergason James L Light blocking and vision restoration apparatus with glint control
US5118801A (en) 1988-09-30 1992-06-02 The Public Health Research Institute Nucleic acid process containing improved molecular switch
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
CA2020958C (en) 1989-07-11 2005-01-11 Daniel L. Kacian Nucleic acid sequence amplification methods
US5494810A (en) 1990-05-03 1996-02-27 Cornell Research Foundation, Inc. Thermostable ligase-mediated DNA amplifications system for the detection of genetic disease
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994073A (en) 1990-08-30 1999-11-30 Tropix, Inc. Enhancement of chemiluminescent assays
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5539082A (en) 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
US5714331A (en) 1991-05-24 1998-02-03 Buchardt, Deceased; Ole Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility
US5565332A (en) 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US5270184A (en) 1991-11-19 1993-12-14 Becton, Dickinson And Company Nucleic acid target generation
ATE198358T1 (de) 1992-04-27 2001-01-15 Dartmouth College Detektion von gensequenzen in biologischen flüssigkeiten
WO1994010300A1 (en) 1992-10-30 1994-05-11 The General Hospital Corporation Interaction trap system for isolating novel proteins
DE69433811T2 (de) 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995011995A1 (en) 1993-10-26 1995-05-04 Affymax Technologies N.V. Arrays of nucleic acid probes on biological chips
US6027923A (en) 1993-07-23 2000-02-22 Bio-Rad Laboratories, Inc. Linked linear amplification of nucleic acids
US5527675A (en) 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
US5498531A (en) 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
DE4331012A1 (de) 1993-09-13 1995-03-16 Bayer Ag Nukleinsäuren-bindende Oligomere mit N-Verzweigung für Therapie und Diagnostik
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5705333A (en) 1994-08-05 1998-01-06 The Regents Of The University Of California Peptide-based nucleic acid mimics(PENAMS)
US5773628A (en) 1994-11-14 1998-06-30 Tropix, Inc. 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use
US5591591A (en) 1995-02-09 1997-01-07 Tropix, Inc. Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore
US5589136A (en) 1995-06-20 1996-12-31 Regents Of The University Of California Silicon-based sleeve devices for chemical reactions
GB9517780D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5801115A (en) 1995-09-05 1998-09-01 Kataleuna Gmbh Catalyst composition and methods for using and preparing same
US5679803A (en) 1995-10-25 1997-10-21 Tropix, Inc. 1,2 chemiluminescent dioxetanes of improved performance
EP2332957B1 (en) 1996-02-09 2015-04-08 Cornell Research Foundation, Inc. Detection of nucleic and acid sequence differences using the ligase detection reaction with addressable arrays
US5885470A (en) 1997-04-14 1999-03-23 Caliper Technologies Corporation Controlled fluid transport in microfabricated polymeric substrates
JP2000508912A (ja) 1996-04-19 2000-07-18 スペクトラ バイオメディカル，インコーポレイテッド 多型形態と複数の表現型との相関付け
EP2369007B1 (en) 1996-05-29 2015-07-29 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions
US5866336A (en) 1996-07-16 1999-02-02 Oncor, Inc. Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US6117635A (en) 1996-07-16 2000-09-12 Intergen Company Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon
US5800999A (en) 1996-12-16 1998-09-01 Tropix, Inc. Dioxetane-precursor-labeled probes and detection assays employing the same
US6234964B1 (en) 1997-03-13 2001-05-22 First Opinion Corporation Disease management system and method
WO1998049548A1 (en) 1997-04-25 1998-11-05 Caliper Technologies Corporation Microfluidic devices incorporating improved channel geometries
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
WO2002072889A2 (en) 2001-01-12 2002-09-19 Applera Corporation Methods and compositions for microarray control
WO2005056837A2 (en) * 2003-11-26 2005-06-23 Applera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
WO2006099365A2 (en) * 2005-03-11 2006-09-21 Applera Corporation Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
US7799530B2 (en) * 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7912068B2 (en) * 2007-07-20 2011-03-22 Oracle America, Inc. Low-latency scheduling in large switches
US20090221620A1 (en) * 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
EP2811758B1 (en) 2013-06-06 2016-11-02 Harman Becker Automotive Systems GmbH Audio signal mixing
CN104538553B (zh) * 2014-12-31 2017-08-04 北京维信诺科技有限公司 一种颜色可调的有机电致发光器件

Similar Documents

Publication Publication Date Title
JP2013524810A5 (https=)
JP2011517281A5 (https=)
JP6839779B2 (ja) スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP2013542735A5 (https=)
Koch et al. Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population
Elmore et al. Identification of a genetic variant associated with abdominal aortic aneurysms on chromosome 3p12. 3 by genome wide association
JP2017507130A5 (https=)
JP2014530819A5 (https=)
US20140044668A1 (en) Methods for Predicting Cardiovascular Risks and Responsiveness to Statin Therapy Using SNPs
ES2211568T3 (es) Prueba genetica para determinar la falta de respuesta al tratamiento farmacologico con estatina.
EP1186672B1 (en) Polymorphisms in the human organic anion transporter C (OATP-C) gene
CN104711344A (zh) 华法林个体化用药基因检测试剂盒及应用
EP2568052B1 (en) Method for producing an amplicon comprising a gene region having various variations and being useful in mass spectrometry
US20240011097A1 (en) Composition for diagnosis or prediction of metabolic syndrome or group at high risk of expression of blood ceramide
JP2015156853A (ja) アルコール代謝遺伝子を検出する方法およびキット
Niihara et al. Simple and rapid detection of HLA-A* 31: 01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method
Mizugaki et al. Rapid detection of CYP2C18 genotypes by real‐time fluorescence polymerase chain reaction
KR101304535B1 (ko) Ｋｌｏｔｈｏ 유전자의 단일염기다형을 이용한 심혈관계 질환 예측 방법
Yehya et al. Cholesteryl ester transfer protein rs1532624 gene polymorphism is associated with reduced response to statin therapy
JP6286904B2 (ja) ＳＮＰ（ｒｓ８１０３１４２）を検出するためのプローブ
JP7731565B2 (ja) Ｂ型肝炎ワクチンに対する免疫応答性の遺伝的要因を検出する方法及び試薬
US20090192135A1 (en) Human Niemann Pick C1-Like 1 Gene (NPC1L1) Polymorphisms and Methods of Use Thereof
JP2011010618A (ja) 糖尿病患者の動脈硬化性疾患の罹患リスクを判定する方法、およびそれに使用する検査薬
WO2011115033A1 (ja) Ｃ型肝炎の治療効果を予測するためのマーカー群、検査方法及び検査用キット
JP6268743B2 (ja) ＳＮＰ（ｒｓ１２９７９８６０）を検出するためのプローブ